Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keefe, Bruyette & Woods Maintains Outperform on Trustmark, Lowers Price Target to $43

Author: Benzinga Newsdesk | April 24, 2025 11:35am
Keefe, Bruyette & Woods analyst Catherine Mealor maintains Trustmark (NASDAQ:TRMK) with a Outperform and lowers the price target from $45 to $43.

Posted In: TRMK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist